List of insiders holdings for Senti Biosciences Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
| 1 | Celadon Partners SPV 24 10% Owner |
2025-03-17 15:01:38 | 9,777,000 0 |
9,777,000 | Form 13D |
| 2 | Dynamics Sponsor LLC Director 10% Owner |
2022-06-10 21:20:32 | 6,465,500 0 |
6,465,500 | Form 4 |
| 3 | Ronaghi Mostafa Chief Executive Officer |
2021-05-25 20:19:14 | 0 6,465,500 |
6,465,500 | Form 3 |
| 4 | BAYER HEALTHCARE LLC Bayer US Holding LP Bayer World Investments B.V. BAYER AKTIENGESELLSCHAFT 10% Owner |
2025-03-17 18:35:12 | 6,142,848 0 |
6,142,848 | Form 13D |
| 5 | New Enterprise Associates 15 L.P. NEA Partners 15 L.P. NEA 15 GP LLC BASKETT FOREST Florence Anthony A. Jr. Makhzoumi Mohamad SANDELL SCOTT D 10% Owner |
2025-03-12 21:30:38 | 3,775,615 0 |
3,775,615 | Form 4 |
| 6 | New Enterprise Associates 15 L.P. NEA Partners 15 L.P. NEA 15 GP LLC BASKETT FOREST Florence Anthony A. Jr. SANDELL SCOTT D Makhzoumi Mohamad Sonsini Peter W. 10% Owner |
2025-03-10 19:00:58 | 3,775,615 0 |
3,775,615 | Form 13D |
| 7 | Lu Timothy K CEO and Interim PFO and PAO |
2025-03-10 19:01:31 | 2,651,513 105,678 |
2,757,191 | Form 4 |
| 8 | Herberts Curt A. III Chief Operating Officer |
2022-06-15 18:00:32 | 1,292,862 493,414 |
1,786,276 | Form 3 |
| 9 | KNOBELMAN DEBORAH Chief Financial Officer |
2024-02-02 17:24:38 | 283,000 0 |
283,000 | Form 4 |
| 10 | Lee Philip J Chief Technology Officer |
2023-02-02 17:21:17 | 195,000 0 |
195,000 | Form 4 |
| 11 | Cross John Harry III Chief Financial Officer |
2025-03-11 16:14:50 | 174,200 0 |
174,200 | Form 4 |
| 12 | Epstein David R Director |
2022-07-15 18:00:25 | 125,000 0 |
125,000 | Form 4 |
| 13 | FLATLEY JAY T Director |
2021-05-25 20:23:54 | 0 123,252 |
123,252 | Form 3 |
| 14 | Nishar Dipchand Director |
2021-05-25 20:26:24 | 0 123,252 |
123,252 | Form 3 |
| 15 | Rajangam Kanya Pres. & Chief Med. & Dev. Off. |
2025-03-11 16:23:45 | 86,984 33,000 |
119,984 | Form 4 |
| 16 | Farokhzad Omid Director |
2024-07-12 16:17:24 | 62,500 0 |
62,500 | Form 4 |
| 17 | Berland Susan D Director |
2023-06-21 19:14:48 | 62,500 0 |
62,500 | Form 4 |
| 18 | Hsiung Feng Director |
2025-03-11 16:17:16 | 43,900 0 |
43,900 | Form 4 |
| 19 | COOPERSTONE BRENDA Director |
2025-03-11 16:20:31 | 43,900 0 |
43,900 | Form 4 |
| 20 | Tang Donald F Director |
2025-03-11 16:20:44 | 43,900 0 |
43,900 | Form 4 |
| 21 | Collins James J. Director |
2025-03-11 16:20:53 | 43,900 0 |
43,900 | Form 4 |
| 22 | Schulz Fran Director |
2025-03-11 16:21:02 | 43,900 0 |
43,900 | Form 4 |
| 23 | Mathers Edward T Director |
2025-03-11 16:28:11 | 43,900 0 |
43,900 | Form 4 |
| 24 | Li Yvonne Interim CFO |
2024-05-09 16:19:15 | 0 0 |
0 | Form 3 |
| 25 | Afrasiabi Mark Chief Financial Officer |
2021-05-25 20:24:20 | 0 0 |
0 | Form 3 |
| 26 | Chapman Rowan E Chief Business Officer |
2021-05-25 20:23:28 | 0 0 |
0 | Form 3 |